Budget Amount *help |
¥403,260,000 (Direct Cost: ¥310,200,000、Indirect Cost: ¥93,060,000)
Fiscal Year 2014: ¥74,100,000 (Direct Cost: ¥57,000,000、Indirect Cost: ¥17,100,000)
Fiscal Year 2013: ¥77,740,000 (Direct Cost: ¥59,800,000、Indirect Cost: ¥17,940,000)
Fiscal Year 2012: ¥81,510,000 (Direct Cost: ¥62,700,000、Indirect Cost: ¥18,810,000)
Fiscal Year 2011: ¥80,730,000 (Direct Cost: ¥62,100,000、Indirect Cost: ¥18,630,000)
Fiscal Year 2010: ¥89,180,000 (Direct Cost: ¥68,600,000、Indirect Cost: ¥20,580,000)
|
Outline of Final Research Achievements |
Applying comprehensive genome sequencing with next generation sequencers, we conducted molecular genetics studies to elucidate molecular bases of hereditary neurodegenerative diseases as well as sporadic neurodegenerative diseases. We discovered the causative gene (TFG) for Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P). We also discovered the causative gene (ERBB4) for familial amyotrophic lateral sclerosis (ALS19). Regarding sporadic neurodegenerative diseases, we discovered that COQ2 is the causative gene for familial multiple system atrophy (MSA), and furthermore, multiple rare variants of COQ2 increase the risk for developing sporadic MSA.
|